Oslo, Norway

Egil Jellum

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Olso, NO (2007)
  • Oslo, NO (2015)

Company Filing History:


Years Active: 2007-2015

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Egil Jellum

Introduction

Egil Jellum, based in Oslo, Norway, is an accomplished inventor known for his significant contributions to medical advancements. With a total of two patents to his name, Jellum has focused his research on treatments aimed at alleviating pain associated with sub-dermal soft tissue.

Latest Patents

Egil Jellum's most recent patents revolve around a novel strontium compound designed for the treatment of sub-dermal soft tissue pain. This innovative method provides an effective treatment for both human and non-human subjects by administering a physiologically tolerable strontium compound to individuals suffering from this specific type of pain. His work in this area is notable for its potential impact on pain management solutions.

Career Highlights

Jellum has been a part of Santosolve AS, where he has contributed his expertise in developing medical treatments. His role at the company has allowed him to explore and implement various innovative solutions in physiotherapy and pain relief.

Collaborations

Throughout his career, Egil Jellum has collaborated with talented professionals such as Bjørn Jarl Fagerlund and Clas Magne Kjølberg. These partnerships reflect a shared commitment to advancing healthcare through innovative inventions that address significant medical needs.

Conclusion

Egil Jellum's innovative approach to treating sub-dermal soft tissue pain showcases his dedication to improving medical interventions. His contributions, supported by his patents and collaborations, underline the important role of inventors in the field of healthcare innovation. As he continues to develop new solutions, the impact of his work will undoubtedly resonate within the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…